Cardiol Therapeutics Inc.

TSX:CRDL.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$1.36 +0.67%

+$0.00 today

Market cap
$164.10M
Beta
0.48
P/E (TTM)
-4.5
EPS (TTM)
-$0.33
52W Low $1.23High $2.33

Volume 0.08M

Average 0.12M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$34.32M

FY 2025 · Annual

Net Income

-$33.82M

FY 2025 · Annual

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue78.76K0000
Cost of Revenue220.42K219.91K248.36K373.11K101.98K
Gross Profit78.76K(219.91K)(248.36K)(373.11K)(101.98K)
Gross Margin100.0%————
Research & Development10.87M18.96M14.22M14.01M14.02M
Selling, General & Admin27.87M22.37M15.56M25.89M20.2M
Operating Expenses38.74M41.34M29.54M39.9M34.32M
Depreciation & Amortization220.42K219.91K248.36K373.11K101.98K
EBITDA(38.44M)(30.71M)(27.88M)(36.3M)(34.21M)
EBITDA Margin-48812.1%————
Operating Income(45.47M)(50.34M)(29.79M)(40.28M)(34.32M)
Operating Margin-57736.3%————
Interest Income106K1.24M2.04M1.19M726.4K
Interest Expense00000
Other Income / Expenses7.03M10.41M1.66M3.6M497.42K
Income Before Tax(31.64M)(30.93M)(28.13M)(36.68M)(33.82M)
Pre-Tax Margin-40170.4%————
Income Tax Expense(6.91M)(19.41M)000
Net Income(24.72M)(11.52M)(28.13M)(36.68M)(33.82M)
Net Margin-31391.5%————
EPS (Basic)(0.57)(0.18)(0.44)(0.51)(0.39)
EPS (Diluted)(0.57)(0.18)(0.44)(0.51)(0.39)
Weighted Avg Shares43.22M62.51M64.46M71.57M86.99M
Weighted Avg Shares (Diluted)43.22M62.51M64.46M71.57M86.99M

CRDL.TO Earnings Waterfall · TTM

TSX:CRDL.TO · Revenue to Net Income

Key Ratios

EPS$-0.39
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$36.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.39, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

No filings found.

How much revenue does CRDL.TO generate?

Cardiol Therapeutics Inc. (CRDL.TO) reported $0.00 of revenue in fiscal 2025.

Is CRDL.TO profitable?

Cardiol Therapeutics Inc. (CRDL.TO) reported -$33.82M of net income.